SGRY Surgery Partners, Inc.
$14.38▲ +1.84%
Healthcare
Other
After hours
$14.37▼ -0.07%
Sep 11, 7:30 PM ET
Volume 1.29M
Avg Volume (10D) 2.33M
Key Metrics & Fundamentals
Market Cap
$1.88B
P/E Ratio
–
Div Yield
–%
52W Range
11.41 - 23.44
% vs 50 MA
-5.31%
% vs 200 MA
-2.34%
RSI-14
49.1
MACD Histogram
+0.0700
Beta (1Y vs SPY)
0.69
Free Cash Flow
$37.50M
Gross Rev
$848.90M
Gross Profit
$190.20M
EBITDA
$162.20M
COGS
$658.70M
Operating Exp
$73.70M
Operating Income
$116.50M
EBIT
$116.50M
Pretax Income
$32.30M
Net Income
-$15.00M
EPS (Diluted)
-0.12
Price & Volume History
Loading chart…
Recent News

Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
Motley Fool · Sep 3, 2026 5:20 PM

3 Cash-Producing Stocks Walking a Fine Line
StockStory · Aug 27, 2026 2:41 PM

Surgery Partners (SGRY) Stock May Be Undervalued After Q2 Earnings Beat
Simply Wall St. · Aug 20, 2026 1:12 AM

Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 17, 2026 3:14 PM

The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call
StockStory · Aug 17, 2026 6:30 AM

1 of Wall Street’s Favorite Stocks to Research Further and 2 We Avoid
StockStory · Aug 16, 2026 5:57 PM

Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY)
StockStory · Aug 15, 2026 5:57 PM

SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift
StockStory · Aug 13, 2026 4:45 AM
Surgery Partners (SGRY) Q2 Earnings: What To Expect
StockStory · Aug 11, 2026 11:49 AM
RBC Capital Adjusts Price Target on Surgery Partners to $19 From $20, Keeps Outperform Rating
MT Newswires · Aug 11, 2026 10:51 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See SGRY's money flow as a full page
Social Sentiment
No Reddit posts found for SGRY.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.